When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OTSKF - Akebia down big after vadadustat misses safety endpoints in late-stage studies in CKD anemia
Otsuka Holdings Co. Ltd.
Following up on its announcement of positive data in May, Akebia Therapeutics (NASDAQ:AKBA)announces mixed final results from two open-label Phase 3 clinical trials, PRO2TECT-CONVERSION and PRO2TECT-CORRECTION, evaluating vadadustat in adult chronic kidney disease patients with anemia not on dialysis.
More news on: Akebia Therapeutics, Inc., Amgen Inc., Otsuka Holdings Co., Ltd., Healthcare stocks news, Stocks on the move,